Phase 2 N=49 A Study of Imatinib and Docetaxel in Prostate Cancer
Prostate Cancer
Primary: Overall Time To Progression (TTP) — 6.4 months
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=53 Xylitol Versus Saline in Chronic Sinusitis
Chronic Sinusitis
Primary: SNOT-20 Scores at 12 Weeks — 7; 11 units on a scale
Phase 2 N=33 Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma
Adult Giant Cell Glioblastoma · Adult Glioblastoma · Adult Gliosarcoma
Primary: Arm 1: Progression Free Survival (PFS) — 0; 0 Participants
N/A N=108 Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Breast Carcinoma · Cancer · Fatigue
Primary: Mean Change (6 Weeks - Baseline) and Standard Deviation in Cancer-related Fatigue, Using the Brief Fatigue Inventory-Short Form (BFI-SF) and Multidimensional Fatigue…
Phase 2 N=301 Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis
Ankylosing Spondylitis
Primary: Percentage of Participants Who Achieved 20% Response According to the Assessment in Ankylosing Spondylitis (AS) Working Group Criteria for Response (ASAS20) at Week 12…
Phase 4 N=20 Evaluation Exparel Delivered in Knee Replacement
Arthritis
Primary: Subjective Pain — 3.80; 4.00; 3.44; 5.30 units on a scale
Phase 2 N=9 CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma
Pancreatic Neoplasms · Bile Duct Neoplasms
Primary: Overall Response Rate — 1; 1; 3; 1 participants
Phase 3 N=546 To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
Rheumatoid Arthritis
Primary: Percentage of Participants Who Achieved at Least 20% Improvement in the American College of Rheumatology (ACR20) Criteria at Week 24 — 33.7; 55.8; 60.9 percentage of…
N/A N=693 Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy
Fatigue · Unspecified Adult Solid Tumor, Protocol Specific
Primary: Change of Cancer-related Fatigue as Assessed by the Brief Fatigue Inventory (BFI) Total Score at Day 41 (After Exercise Intervention) Minus BFI Total Score at Day 0…
Phase 2 N=40 Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo
Seizure Disorder · Hypogonadism · Erectile Dysfunction
Primary: Sexual Function Scores, Calculated Using S-Score and Reynolds' Sexual Questionnaires, Will Increase More Anastrozole and Testosterone Treatment Than With Placebo and…
N/A N=169 Screening for Chronic Obstructive Pulmonary Disease in Patients With Acute Coronary Syndromes
Chronic Obstructive Pulmonary Disease · Acute Coronary Syndromes
Primary: COPD Diagnosis — 39 participants
N/A N=48 Differences in Muscle Activity Patterns and Graphical Product Quality in Children With Graphomotor Impairment
Graphomotor Impairment
Primary: Normilized Muscle Activity — 8.20; 7.41 % mvc — p=0.05
Phase 3 N=443 Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children
Infections, Streptococcal
Primary: Antibody Concentrations Against Vaccine Pneumococcal Serotypes — 1.24; 7.63; 4.52; 12.95 μg/mL
N/A N=168 Late Hypothermia for Hypoxic-Ischemic Encephalopathy
Infant, Newborn · Hypoxia, Brain · Hypoxia-Ischemia, Brain
Primary: Death or Moderate or Severe Disability — 19; 22 Participants
N/A N=219 HIV-Tb Confections Among HIV Patients
HIV
Primary: Prevalence of HIV/Tb. co Infections Among Patients of HIV Enrolled at ART Center. — 48 participants